A critical shortage of Cisplatin and Carboplatin, two widely used chemotherapy drugs, is disrupting cancer treatment across India. Hospitals report rapidly dwindling stocks, with some having only days of supply left. Doctors warn that prolonged shortages could delay treatment, increase patient distress, and potentially affect outcomes for those undergoing curative cancer therapy.